Status:
COMPLETED
Short- and Long-term Outcomes of Stenting for Symptomatic Intracranial Arterial Stenosis: a Cohort Study
Lead Sponsor:
Sohag University
Conditions:
Intracranial Atherosclerosis
Eligibility:
All Genders
18-85 years
Brief Summary
The purpose of this study is to assess short and long term outcomes of stenting for symptomatic intracranial arterial stenosis.
Eligibility Criteria
Inclusion
- Participants had a symptomatic intracranial stenosis of 70-99 percentage (%) with a lesion length of ≤15 mm and target vessel diameter of ≥2.0 mm in the intracranial internal carotid, middle cerebral, intracranial vertebral or basilar arteries and the measurements of stenosis will be made on magnetic resonance angiography (MRA) using the Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) trial method and confirmed by digital subtraction angiography (DSA).
- Presented with transient ischemic attack (TIA) or stroke within the past 12 months attributed to the stenosis.
Exclusion
- Participants with acute infarctions within the past 3 weeks.
- Severe arterial tortuosity prevents the deployment of endovascular devices.
- Non-atherosclerotic lesion on magnetic resonance imaging (MRI), embolic or perforator stroke on MRI or computerized tomography (CT).
- A baseline modified Rankin Scale (mRS) score of \>3.
- Massive cerebral infarction (\>1/2 middle cerebral artery (MCA) territory), intracranial hemorrhage, epidural or sub-dural hemorrhage, and intracranial brain tumor on CT or MRI scan.
Key Trial Info
Start Date :
March 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 20 2024
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT05203887
Start Date
March 1 2022
End Date
February 20 2024
Last Update
April 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain shams university
Cairo, Egypt